Medical News and Events in South Africa
Medical News and Events in South Africa

Medical Industry News Archive

Click here to search our archive

Print using browser

URGENT MEDICINE RECALL: SANDOZ CEFPODOXIME 40mg/5ml Reg No A39/20.1.1/0397 (50ml and 100ml pack sizes)
Sandoz SA (Pty) Ltd in collaboration with the Medicines Control Council are initiating a Class 2, Type B recall on all batches of Sandoz Cefpodoxime 40mg /5ml (50ml and 100ml pack sizes).

Sandoz Cefpodoxime 40mg/5ml powder for oral suspension is an antibiotic used for short- term treatment of lower and upper respiratory tract infections in infants, children and adults.

The product is being recalled due to lower than expected efficacy, high unknown impurities, discolouration and formation of brownish agglomerates on certain batches of Sandoz Cefpodoxime 40mg/5ml tested during stability monitoring.

Use of the product may lead to weakened patient therapy through insufficient anti-infective treatment resulting in: a patient being contagious to others for a longer time, the development and spread of resistant bacterial strains, and significant therapeutic difficulties in eradication of respective bacteria.

In the interest of patient safety, Sandoz SA (Pty) Ltd request that you immediately return all batches of Sandoz Cefpodoxime 40mg/5ml stock without delay to your supplying wholesaler or distributor for full credit.
Sandoz SA (Pty) Ltd would like to thank you for your co-operation and apologise for any inconvenience caused.

Should you have any enquiries in this regard kindly contact the Sandoz Customer Call Centre 0861 SANCAL or 0861 726 225 during office hours and a technical support 24 hour call no 0768114744.

For full prescribing information please refer to package insert approved by Medical Regulatory Authority

Sandoz SA (Pty) Ltd PO Box 154, Isando 1600 Kempton Park, Gauteng South Africa Tel Fax +27 (0) 11 394 3084    Reg No: 1990/001979/07
Directors: R-A Bassoul (Canadian) J-C Dubos (French) M.M Paleja (Singaporean)  
A Novartis Company

You need to be logged in to see more details. Register Now!

Click here for more information .....
Contact: Carla Urbani-Smith, (Responsible Pharmacist)
Telephone: +27 (0) 11 929 9000
Date: Tuesday, February 14, 2012

Archive News Headlines
Adcock - Back in stock - Urizone 3 gm Sachet (Fosfomycin)
Ranbaxy - Stock shortage - Simvotin 20 mg and 40 mg 28’s (simvastatin)
Austell Laboratories - Stock Outages - Austell Ramipril 2.5 mg, 5 mg & 10 mg tablets
Sandoz - Stock Outage - Ranihexal 300 mg tablets (Ranitidine)
Adcock - Stock Outage - Urizone 3 gm Sachet (Fosfomycin)
Norgine - Stock Outage - Camcolit 250mg 100’s (lithium carbonate)
Boehringer Ingelheim discontinue Michol 10 mg, 20 mg, 40mg and 80 mg Tablets (Simvastatin)
Aspen - Stock Outage - Prezista 75 mg and 150 mg tablets (darunavir ethanolate)
Bayer - Discontinue Glucobay 50 and 100 mg tablets (acarbose)
Cipla - Stock Availability- Maxaderm Cream (isoconazole,diflucortolone)
Ranbaxy - Stock shortage - Diaran MR tablets (gliclazide 30 mg)
Equity Pharmaceuticals - launch - Intramol 1 g/100 ml (paracetamol)
Genop Healthcare - launch - Xailin Gel
Aspen - Stock Outage - Loramet 1 mg and 2 mg capsules (lormetazepam)
Ranbaxy - Stock shortage - Alapren 5 mg & 10 mg (enalapril maleate)
Cipla - Stock Outage - Foratec DP Capsules (Formoterol Fumarate)
Mundipharma - launch - Betadine First Aid Cream (Povidone - Iodine)
Takeda - Stock Availability - Legalon Tablets (silymarin)
Mundipharma - launch - Betadine Medicated Shampoo (Povidone - Iodine)
Novagen Pharma - launch - Densate 70 mg (alendronate)